Your browser doesn't support javascript.
loading
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
Kim, Kevin B; Soroceanu, Liliana; de Semir, David; Millis, Sherri Z; Ross, Jeffrey; Vosoughi, Elham; Dar, Altaf A; Nosrati, Mehdi; Desprez, Pierre-Yves; Ice, Ryan; Chen, Michelle; Chetal, Kashish; Bhattacharjee, Anukana; Moretto, John; Leong, Stanley P; Singer, Mark I; Parrett, Brian M; Minor, David R; McAllister, Sean; Miller, James R; Salomonis, Nathan; Kashani-Sabet, Mohammed.
Afiliação
  • Kim KB; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA. Electronic address: kimkb@sutterhealth.org.
  • Soroceanu L; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • de Semir D; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Millis SZ; Foundation Medicine, Cambridge, Massachusetts, USA.
  • Ross J; Foundation Medicine, Cambridge, Massachusetts, USA; Upstate Medical University, Syracuse, New York, USA.
  • Vosoughi E; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Dar AA; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Nosrati M; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Desprez PY; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Ice R; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Chen M; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Chetal K; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Bhattacharjee A; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Moretto J; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA.
  • Leong SP; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA.
  • Singer MI; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA.
  • Parrett BM; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA.
  • Minor DR; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA.
  • McAllister S; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Miller JR; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA.
  • Salomonis N; Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Kashani-Sabet M; Center for Melanoma Research and Treatment, California Pacific Medical Center, San Francisco, California, USA; California Pacific Medical Center Research Institute, San Francisco, California, USA.
J Invest Dermatol ; 141(8): 2028-2036.e2, 2021 08.
Article em En | MEDLINE | ID: mdl-33610559
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Biomarcadores Tumorais / Reparo de DNA por Recombinação / Melanoma Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: J Invest Dermatol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Biomarcadores Tumorais / Reparo de DNA por Recombinação / Melanoma Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: J Invest Dermatol Ano de publicação: 2021 Tipo de documento: Article